Showing results (31-40 of 88) with videos related to
Sort By:
Pageof 9
American Journal of Hematology|January 3, 2022
Impact of achieving a complete response to initial therapy of multiple myeloma and predictors of subsequent outcomeMarcella Kaddoura, Moritz Binder, David Dingli, et al.American Journal of Hematology|July 18, 2018
Serum free light chain measurements to reduce 24-h urine monitoring in patients with multiple myeloma with measurable urine monoclonal proteinMarcella Tschautscher, Vincent Rajkumar, Angela Dispenzieri, et al.American Journal of Hematology|December 16, 2020
Outcomes with different administration schedules of bortezomib in bortezomib, lenalidomide and dexamethasone (VRd) as first-line therapy in multiple myelomaJoselle Cook, Isla Johnson, Alexandra Higgins, et al.Leukemia|December 16, 2024
Capillary leak phenotype as a major cause of death in patients with POEMS syndromeKenzie Lee, Taxiarchis Kourelis, Marcella Tschautscher, et al.Haematologica|May 22, 2025
Clonal plasma cell features in light-chain amyloidosis are associated with depth and timing of cardiac response independent of hematologic responseMatthew J Rees, Susan Geyer, Binoy Yohannan, et al.Blood|October 13, 2016
The prognostic value of multiparametric flow cytometry in AL amyloidosis at diagnosis and at the end of first-line treatmentEli Muchtar, Dragan Jevremovic, Angela Dispenzieri, et al.Leukemia|September 28, 2025
Refining PET-based response in extramedullary multiple myeloma using total lesion glycolysisSaurabh Zanwar, Gokce Belge Bilgin, Stephen M Broski, et al.American Journal of Hematology|January 2, 2023
Thrombosis in multiple myeloma: Risk estimation by induction regimen and association with overall survivalCharalampos Charalampous, Utkarsh Goel, Prashant Kapoor, et al.Cancer Medicine|October 6, 2020
Colon perforation in multiple myeloma patients - A complication of high-dose steroid treatmentIuliana Vaxman, Abdullah S Al Saleh, Shaji Kumar, et al.Blood Advances|April 12, 2022
Outcomes after biochemical or clinical progression in patients with multiple myelomaSarah Goldman-Mazur, Alissa Visram, Prashant Kapoor, et al.Pageof 9